Jan 28 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS PROVIDES INVESTOR UPDATE ON THE CANADIAN LAUNCH OF VASCEPA® (ICOSAPENT ETHYL)
* HLS THERAPEUTICS INC - VASCEPA TO BE AVAILABLE ON OR ABOUT FEBRUARY 18, 2020, SUPPORTED BY A NATIONAL CARDIOVASCULAR SALESFORCE
* HLS THERAPEUTICS INC - VASCEPA IS SUPPORTED BY DATA FROM REDUCE-IT TRIAL